nodes	percent_of_prediction	percent_of_DWPC	metapath
Cladribine—Cholecystitis—Octreotide—thymus cancer	0.02	0.0429	CcSEcCtD
Cladribine—POLE2—bone marrow—thymus cancer	0.0176	0.0328	CbGeAlD
Cladribine—PNP—hematopoietic system—thymus cancer	0.0173	0.0324	CbGeAlD
Cladribine—Redness—Octreotide—thymus cancer	0.017	0.0365	CcSEcCtD
Cladribine—RRM2B—hematopoietic system—thymus cancer	0.0161	0.0301	CbGeAlD
Cladribine—POLE2—lung—thymus cancer	0.0159	0.0297	CbGeAlD
Cladribine—Neuritis—Octreotide—thymus cancer	0.0154	0.033	CcSEcCtD
Cladribine—Herpes zoster—Octreotide—thymus cancer	0.0152	0.0327	CcSEcCtD
Cladribine—POLE3—hematopoietic system—thymus cancer	0.0152	0.0284	CbGeAlD
Cladribine—NR5A1—hematopoietic system—thymus cancer	0.0147	0.0275	CbGeAlD
Cladribine—Petechiae—Octreotide—thymus cancer	0.0139	0.03	CcSEcCtD
Cladribine—Neoplasm malignant—Octreotide—thymus cancer	0.0134	0.0289	CcSEcCtD
Cladribine—Contusion—Octreotide—thymus cancer	0.0131	0.0283	CcSEcCtD
Cladribine—Extravasation—Octreotide—thymus cancer	0.0131	0.0283	CcSEcCtD
Cladribine—Cellulitis—Octreotide—thymus cancer	0.0126	0.0271	CcSEcCtD
Cladribine—RRM2B—cardiac atrium—thymus cancer	0.0122	0.0228	CbGeAlD
Cladribine—PNP—lymphoid tissue—thymus cancer	0.0122	0.0228	CbGeAlD
Cladribine—RRM2B—pituitary gland—thymus cancer	0.0119	0.0223	CbGeAlD
Cladribine—POLE—hematopoietic system—thymus cancer	0.0116	0.0217	CbGeAlD
Cladribine—POLE3—cardiac atrium—thymus cancer	0.0115	0.0216	CbGeAlD
Cladribine—Injection site reaction—Octreotide—thymus cancer	0.0114	0.0245	CcSEcCtD
Cladribine—POLE3—pituitary gland—thymus cancer	0.0113	0.0211	CbGeAlD
Cladribine—Wheezing—Octreotide—thymus cancer	0.0111	0.0239	CcSEcCtD
Cladribine—PNP—bone marrow—thymus cancer	0.0111	0.0208	CbGeAlD
Cladribine—Candida infection—Octreotide—thymus cancer	0.0109	0.0235	CcSEcCtD
Cladribine—NR5A1—pituitary gland—thymus cancer	0.0109	0.0204	CbGeAlD
Cladribine—POLE2—lymph node—thymus cancer	0.0109	0.0203	CbGeAlD
Cladribine—POLE3—lymphoid tissue—thymus cancer	0.0107	0.02	CbGeAlD
Cladribine—NR5A1—lymphoid tissue—thymus cancer	0.0104	0.0194	CbGeAlD
Cladribine—RRM2B—bone marrow—thymus cancer	0.0103	0.0193	CbGeAlD
Cladribine—RRM2B—thyroid gland—thymus cancer	0.0103	0.0192	CbGeAlD
Cladribine—PNP—lung—thymus cancer	0.0101	0.0188	CbGeAlD
Cladribine—POLA1—hematopoietic system—thymus cancer	0.01	0.0187	CbGeAlD
Cladribine—POLE3—bone marrow—thymus cancer	0.00975	0.0182	CbGeAlD
Cladribine—POLE3—thyroid gland—thymus cancer	0.00972	0.0182	CbGeAlD
Cladribine—Phlebitis—Octreotide—thymus cancer	0.00966	0.0208	CcSEcCtD
Cladribine—RRM2—hematopoietic system—thymus cancer	0.00955	0.0179	CbGeAlD
Cladribine—RRM2B—lung—thymus cancer	0.00934	0.0175	CbGeAlD
Cladribine—SLC28A3—bone marrow—thymus cancer	0.00912	0.0171	CbGeAlD
Cladribine—POLE3—lung—thymus cancer	0.00883	0.0165	CbGeAlD
Cladribine—POLE—pituitary gland—thymus cancer	0.0086	0.0161	CbGeAlD
Cladribine—Arthritis—Octreotide—thymus cancer	0.00856	0.0184	CcSEcCtD
Cladribine—Pain in extremity—Octreotide—thymus cancer	0.00832	0.0179	CcSEcCtD
Cladribine—SLC28A3—lung—thymus cancer	0.00826	0.0154	CbGeAlD
Cladribine—POLE—lymphoid tissue—thymus cancer	0.00817	0.0153	CbGeAlD
Cladribine—RRM1—hematopoietic system—thymus cancer	0.00794	0.0148	CbGeAlD
Cladribine—POLE—bone marrow—thymus cancer	0.00744	0.0139	CbGeAlD
Cladribine—POLE—thyroid gland—thymus cancer	0.00742	0.0139	CbGeAlD
Cladribine—POLA1—pituitary gland—thymus cancer	0.00742	0.0139	CbGeAlD
Cladribine—Muscular weakness—Octreotide—thymus cancer	0.00734	0.0158	CcSEcCtD
Cladribine—RRM2—pituitary gland—thymus cancer	0.00709	0.0132	CbGeAlD
Cladribine—Sweating increased—Octreotide—thymus cancer	0.00701	0.0151	CcSEcCtD
Cladribine—Abdominal discomfort—Octreotide—thymus cancer	0.00689	0.0148	CcSEcCtD
Cladribine—POLE—lung—thymus cancer	0.00674	0.0126	CbGeAlD
Cladribine—RRM2—lymphoid tissue—thymus cancer	0.00673	0.0126	CbGeAlD
Cladribine—Upper respiratory tract infection—Octreotide—thymus cancer	0.00668	0.0144	CcSEcCtD
Cladribine—Pneumonia—Octreotide—thymus cancer	0.00645	0.0139	CcSEcCtD
Cladribine—POLA1—bone marrow—thymus cancer	0.00641	0.012	CbGeAlD
Cladribine—POLA1—thyroid gland—thymus cancer	0.00639	0.012	CbGeAlD
Cladribine—RRM2B—lymph node—thymus cancer	0.00639	0.0119	CbGeAlD
Cladribine—Conjunctivitis—Octreotide—thymus cancer	0.00623	0.0134	CcSEcCtD
Cladribine—Urinary tract infection—Octreotide—thymus cancer	0.00623	0.0134	CcSEcCtD
Cladribine—DCK—hematopoietic system—thymus cancer	0.00616	0.0115	CbGeAlD
Cladribine—RRM2—bone marrow—thymus cancer	0.00612	0.0114	CbGeAlD
Cladribine—RRM2—thyroid gland—thymus cancer	0.00611	0.0114	CbGeAlD
Cladribine—Hepatobiliary disease—Octreotide—thymus cancer	0.00606	0.013	CcSEcCtD
Cladribine—Epistaxis—Octreotide—thymus cancer	0.00605	0.013	CcSEcCtD
Cladribine—POLE3—lymph node—thymus cancer	0.00604	0.0113	CbGeAlD
Cladribine—RRM1—cardiac atrium—thymus cancer	0.00603	0.0113	CbGeAlD
Cladribine—RRM1—pituitary gland—thymus cancer	0.00589	0.011	CbGeAlD
Cladribine—POLA1—lung—thymus cancer	0.00581	0.0109	CbGeAlD
Cladribine—Pharyngitis—Octreotide—thymus cancer	0.00571	0.0123	CcSEcCtD
Cladribine—Oedema peripheral—Octreotide—thymus cancer	0.00567	0.0122	CcSEcCtD
Cladribine—RRM1—lymphoid tissue—thymus cancer	0.00559	0.0104	CbGeAlD
Cladribine—RRM2—lung—thymus cancer	0.00555	0.0104	CbGeAlD
Cladribine—Cardiac disorder—Octreotide—thymus cancer	0.00534	0.0115	CcSEcCtD
Cladribine—Immune system disorder—Octreotide—thymus cancer	0.0052	0.0112	CcSEcCtD
Cladribine—Arrhythmia—Octreotide—thymus cancer	0.00514	0.0111	CcSEcCtD
Cladribine—RRM1—bone marrow—thymus cancer	0.00509	0.00951	CbGeAlD
Cladribine—Alopecia—Octreotide—thymus cancer	0.00509	0.0109	CcSEcCtD
Cladribine—RRM1—thyroid gland—thymus cancer	0.00507	0.00949	CbGeAlD
Cladribine—Mental disorder—Octreotide—thymus cancer	0.00504	0.0108	CcSEcCtD
Cladribine—Malnutrition—Octreotide—thymus cancer	0.00501	0.0108	CcSEcCtD
Cladribine—Erythema—Octreotide—thymus cancer	0.00501	0.0108	CcSEcCtD
Cladribine—Flatulence—Octreotide—thymus cancer	0.00494	0.0106	CcSEcCtD
Cladribine—Back pain—Octreotide—thymus cancer	0.00485	0.0104	CcSEcCtD
Cladribine—DCK—cardiac atrium—thymus cancer	0.00468	0.00875	CbGeAlD
Cladribine—Ill-defined disorder—Octreotide—thymus cancer	0.00465	0.01	CcSEcCtD
Cladribine—Anaemia—Octreotide—thymus cancer	0.00463	0.00996	CcSEcCtD
Cladribine—RRM1—lung—thymus cancer	0.00461	0.00862	CbGeAlD
Cladribine—POLE—lymph node—thymus cancer	0.00461	0.00861	CbGeAlD
Cladribine—DCK—pituitary gland—thymus cancer	0.00457	0.00855	CbGeAlD
Cladribine—Malaise—Octreotide—thymus cancer	0.00452	0.00972	CcSEcCtD
Cladribine—Cough—Octreotide—thymus cancer	0.00437	0.0094	CcSEcCtD
Cladribine—DCK—lymphoid tissue—thymus cancer	0.00434	0.00811	CbGeAlD
Cladribine—Myalgia—Octreotide—thymus cancer	0.00427	0.00917	CcSEcCtD
Cladribine—Chest pain—Octreotide—thymus cancer	0.00427	0.00917	CcSEcCtD
Cladribine—Arthralgia—Octreotide—thymus cancer	0.00427	0.00917	CcSEcCtD
Cladribine—Anxiety—Octreotide—thymus cancer	0.00425	0.00914	CcSEcCtD
Cladribine—Unspecified disorder of skin and subcutaneous tissue—Octreotide—thymus cancer	0.00424	0.00911	CcSEcCtD
Cladribine—Discomfort—Octreotide—thymus cancer	0.00422	0.00906	CcSEcCtD
Cladribine—Oedema—Octreotide—thymus cancer	0.00409	0.00879	CcSEcCtD
Cladribine—Infection—Octreotide—thymus cancer	0.00406	0.00874	CcSEcCtD
Cladribine—Nervous system disorder—Octreotide—thymus cancer	0.00401	0.00862	CcSEcCtD
Cladribine—Thrombocytopenia—Octreotide—thymus cancer	0.004	0.00861	CcSEcCtD
Cladribine—Tachycardia—Octreotide—thymus cancer	0.00399	0.00858	CcSEcCtD
Cladribine—Skin disorder—Octreotide—thymus cancer	0.00397	0.00854	CcSEcCtD
Cladribine—POLA1—lymph node—thymus cancer	0.00397	0.00742	CbGeAlD
Cladribine—Hyperhidrosis—Octreotide—thymus cancer	0.00395	0.0085	CcSEcCtD
Cladribine—DCK—bone marrow—thymus cancer	0.00395	0.00739	CbGeAlD
Cladribine—DCK—thyroid gland—thymus cancer	0.00394	0.00737	CbGeAlD
Cladribine—Anorexia—Octreotide—thymus cancer	0.0039	0.00838	CcSEcCtD
Cladribine—RRM2—lymph node—thymus cancer	0.00379	0.00709	CbGeAlD
Cladribine—Musculoskeletal discomfort—Octreotide—thymus cancer	0.00373	0.00801	CcSEcCtD
Cladribine—Insomnia—Octreotide—thymus cancer	0.0037	0.00795	CcSEcCtD
Cladribine—Paraesthesia—Octreotide—thymus cancer	0.00367	0.0079	CcSEcCtD
Cladribine—Dyspnoea—Octreotide—thymus cancer	0.00365	0.00784	CcSEcCtD
Cladribine—Somnolence—Octreotide—thymus cancer	0.00364	0.00782	CcSEcCtD
Cladribine—DCK—lung—thymus cancer	0.00358	0.00669	CbGeAlD
Cladribine—Decreased appetite—Octreotide—thymus cancer	0.00356	0.00765	CcSEcCtD
Cladribine—Gastrointestinal disorder—Octreotide—thymus cancer	0.00353	0.00759	CcSEcCtD
Cladribine—Fatigue—Octreotide—thymus cancer	0.00353	0.00758	CcSEcCtD
Cladribine—Constipation—Octreotide—thymus cancer	0.0035	0.00752	CcSEcCtD
Cladribine—Pain—Octreotide—thymus cancer	0.0035	0.00752	CcSEcCtD
Cladribine—Feeling abnormal—Octreotide—thymus cancer	0.00337	0.00725	CcSEcCtD
Cladribine—Gastrointestinal pain—Octreotide—thymus cancer	0.00334	0.00719	CcSEcCtD
Cladribine—Urticaria—Octreotide—thymus cancer	0.00325	0.00699	CcSEcCtD
Cladribine—Abdominal pain—Octreotide—thymus cancer	0.00323	0.00695	CcSEcCtD
Cladribine—Body temperature increased—Octreotide—thymus cancer	0.00323	0.00695	CcSEcCtD
Cladribine—RRM1—lymph node—thymus cancer	0.00315	0.00589	CbGeAlD
Cladribine—Hypersensitivity—Octreotide—thymus cancer	0.00301	0.00648	CcSEcCtD
Cladribine—Asthenia—Octreotide—thymus cancer	0.00293	0.00631	CcSEcCtD
Cladribine—Pruritus—Octreotide—thymus cancer	0.00289	0.00622	CcSEcCtD
Cladribine—Diarrhoea—Octreotide—thymus cancer	0.0028	0.00602	CcSEcCtD
Cladribine—Dizziness—Octreotide—thymus cancer	0.0027	0.00582	CcSEcCtD
Cladribine—Vomiting—Octreotide—thymus cancer	0.0026	0.00559	CcSEcCtD
Cladribine—Rash—Octreotide—thymus cancer	0.00258	0.00555	CcSEcCtD
Cladribine—Dermatitis—Octreotide—thymus cancer	0.00258	0.00554	CcSEcCtD
Cladribine—Headache—Octreotide—thymus cancer	0.00256	0.00551	CcSEcCtD
Cladribine—ABCG2—pituitary gland—thymus cancer	0.00255	0.00477	CbGeAlD
Cladribine—DCK—lymph node—thymus cancer	0.00245	0.00458	CbGeAlD
Cladribine—Nausea—Octreotide—thymus cancer	0.00243	0.00522	CcSEcCtD
Cladribine—ABCG2—bone marrow—thymus cancer	0.0022	0.00412	CbGeAlD
Cladribine—ABCG2—thyroid gland—thymus cancer	0.0022	0.00411	CbGeAlD
Cladribine—ABCG2—lung—thymus cancer	0.002	0.00373	CbGeAlD
Cladribine—ABCG2—lymph node—thymus cancer	0.00137	0.00255	CbGeAlD
